Malignant vascular disease of the kidney: Nature of the lesions, mediators of disease progression, and the case for bilateral nephrectomy

American Journal of Kidney Diseases

Volumn 27, Issue 4, 1996, Pages 459-475

  Ruggenenti, P ^a   Remuzzi, G ^a  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

angiotensin converting enzyme inhibitors; bilateral nephrectomy; hemolytic uremic syndrome; malignant hypertension; plasma manipulation; scleroderma; Thrombotic microangiopathy; thrombotic thrombocytopenic purpura

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HAPTOGLOBIN; VON WILLEBRAND FACTOR;

BLOOD VESSEL INJURY; DIALYSIS; DISEASE COURSE; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERTENSION ENCEPHALOPATHY; KIDNEY FAILURE; KIDNEY ISCHEMIA; NEPHRECTOMY; PLASMAPHERESIS; RENOVASCULAR HYPERTENSION; REVIEW; SCLERODERMA; SHEAR STRESS; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULAR ENDOTHELIUM;

EID: 0029997318     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90155-9     Document Type: Review

References (0)